Congress Passes Bill to Limit Cost of Insulin to $35 a Month
The pharmaceutical industry has opposed drug price adjustments in social spending and climate legislation, but hasn’t been vocally opposed to the insulin bill. While the bill lowers costs for many individual patients who take insulin, it does nothing to lower the prices paid to companies that do. Instead, insurance companies would only pay a larger …
Continue reading “Congress Passes Bill to Limit Cost of Insulin to $35 a Month”